eli lilly retatrutide phase 3 trial Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal obesity In TRIUMPH-1, participants on 12 mg lost an average of 70.3 lbs (28.3%) over 80 weeks with Eli Lilly Moves Closer To
Pay in 4 interest-free payments of $6.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4

























